行情

CDXS

CDXS

Codexis
NASDAQ

实时行情|Nasdaq Last Sale

21.49
-0.54
-2.45%
盘后: 21.49 0 0.00% 16:01 01/19 EST
开盘
22.10
昨收
22.03
最高
22.67
最低
21.44
成交量
75.01万
成交额
--
52周最高
42.01
52周最低
16.55
市值
13.94亿
市盈率(TTM)
-89.9540
分时
5日
1月
3月
1年
5年
Hedge Funds Have Never Been This Bullish On Codexis, Inc. (CDXS)
In this article we will take a look at whether hedge funds think Codexis, Inc. (NASDAQ:CDXS) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars...
Insider Monkey · 01/12 16:25
What Makes Codexis (CDXS) a New Strong Buy Stock
Codexis (CDXS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks · 01/11 17:00
Codexis (NASDAQ:CDXS) pulls back 6.3% this week, but still delivers shareholders incredible 45% CAGR over 5 years
Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...
Simply Wall St. · 01/04 09:43
3 Synthetic Biology Stocks in Focus With Strong Potential
Zacks.com · 01/04 00:30
Codexis Highlights Launch Of Codex HiTemp Reverse Transcriptase To Address Key Challenges To 1-Step Assays For RNA Detection In PCR Testing, Including COVID-19
Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its Codex® HiTemp Reverse Transcriptase for use in one-step quantitative
Benzinga · 2021/12/15 13:04
Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing
REDWOOD CITY, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its Codex® HiTemp Reverse Transcriptase for use in one-step ...
GlobeNewswire · 2021/12/15 13:00
Cathie Wood 的 ARK Invest 发布了 2021 年 12 月 1 日星期三的基金销售:SHOP、IOVA、REGN、CDXS、INCY、COIN、OPEN、AMZN、LMT
SHOPIFY INC (SHOP) - 34151 IOVANCE BIOTHERAPEUTICS INC (IOVA) - 42230 REGENERON PHARMACEUTICALS INC (REGN) - 6460 CODEXIS INC (CDXS) - 121400 INCYTE CORP (INCY) - 187064 COINBASE GLOBAL INC (COIN) -
Benzinga · 2021/12/02 14:25
Cathie Wood 的 ARK Invest 公布了 2021 年 11 月 30 日星期二的基金销售:Z、PRLB、TSLA、COIN、U、FTCH、CDXS、CSTL、INCY、IOVA、REGN、PINS
ZILLOW GROUP INC (Z) - 10231 PROTO LABS INC (PRLB) - 4749 TESLA INC (TSLA) - 30034 COINBASE GLOBAL INC (COIN) - 158437 UNITY SOFTWARE INC (U) - 325987 FARFETCH LTD (FTCH) - 11744 CODEXIS INC (CDXS) -
Benzinga · 2021/12/01 13:48
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解CDXS最新的财务预测,通过CDXS每股收益,每股净资产,每股现金流等数据分析Codexis近期的经营情况,然后做出明智的投资选择。
分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

37.50%强力推荐
62.50%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测CDXS价格均价为39.38,最高价位45.00,最低价为34.00。
最高45.00
均价39.38
最低34.00
现价21.49
EPS
实际EPS
预期EPS
-0.17-0.12-0.07-0.01
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 209
机构持股: 6,409.81万
持股比例: 98.80%
总股本: 6,487.53万
类型机构数股数
增持
49
172.07万
建仓
27
91.66万
减持
46
241.05万
平仓
14
32.74万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-1.06%
制药与医学研究
-0.76%
高管信息
President/Chief Executive Officer/Director
John Nicols
Chief Financial Officer/Senior Vice President
Ross Taylor
Independent Director
Jennifer Aaker
Independent Director
Stephen Dilly
Independent Director
Byron Dorgan
Independent Director
Esther Martinborough
Independent Director
Alison Moore
Independent Director
David Smith
Independent Director
Dennis Wolf
Independent Director
Patrick Yang
暂无数据
CDXS 简况
Codexis Inc是一家酶工程公司。该公司从事酶和其他蛋白质的发现,开发和销售。该公司通过两个部门运营:高性能酶和新型生物治疗药物。该公司的CodeEvolver技术平台通过将起始酶转化为生物催化剂或治疗候选物来加速生物制剂的发现。该公司已将其CodeEvolver蛋白质工程技术平台和产品商业化到制药市场。该公司的产品包括Codex HiFi热启动DNA聚合酶和Codex HiCap RNA聚合酶。该公司服务于各种行业,包括食品和食品配料,动物饲料,香精,香料和农用化学品。

微牛提供Codexis, Inc.(NASDAQ-CDXS)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CDXS股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CDXS股票基本功能。